Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
November 26, 2012
11/28/2012 November 26, 2012
CoreRx & ViroPro Announce Agreement CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal...
November 19, 2012
11/21/2012 November 19, 2012
Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...
November 8, 2012
11/14/2012 November 8, 2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...
October 25, 2012
10/30/2012 October 25, 2012
Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic...
October 21, 2012
10/24/2012 October 21, 2012
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients Avantor Performance Materials recently announced it has signed a collaboration...
October 11, 2012
10/16/2012 October 11, 2012
Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license...
October 7, 2012
10/10/2012 October 7, 2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company...
September 16, 2012
9/19/2012 September 16, 2012
PharmaTelevision Spotlights Aptalis' Year in Review FDA approvals, revenue gain, and organic business growth are just a few of the...
September 16, 2012
Ei Gains Exclusive World-Wide License September 16, 2012
Metro Charlotte-based Ei has signed agreements with European-based professors and technologists for the exclusive worldwide license of a novel class...
September 10, 2012
9/12/2012 September 10, 2012
Cobra Biologics & Algeta Sign Monoclonal Antibody Agreement Cobra Biologics Ltd and Algeta ASA recently announced a new contract manufacturing...
September 10, 2012
InSite Vision Introduces DuraSite 2 September 10, 2012
InSite Vision Incorporated recently introduced DuraSite 2, its next-generation enhanced drug delivery system that provides a broad platform for developing...
September 3, 2012
9/5/2012 September 3, 2012
Genmab Signs Potential Billion Dollar Agreement Genmab recently announced a global license and development agreement for daratumumab (HuMax-CD38), a human...
August 26, 2012
8/29/2012 August 26, 2012
Synergy Pharmaceuticals Acquires BMS Drug Synergy Pharmaceuticals Inc. recently announced it has signed an Asset Purchase Agreement with Bristol-Myers Squibb...
August 20, 2012
8/22/2012 August 20, 2012
United Drug Acquires Leading Clinical Trials Materials Business United Drug plc recently announced it has reached an agreement to acquire...
August 5, 2012
8/8/2012 August 5, 2012
Researchers Discover New Mechanism Behind Resistance to Cancer Treatment Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence...
July 30, 2012
8/1/2012 July 30, 2012
BD Launches Thin-Wall Needle Technology BD Medical recently announced the launch of the BD Hyflow needle, a unique 27-gauge thin-wall...
July 19, 2012
7/25/2012 July 19, 2012
Agile Therapeutics Raises $40 Million Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was...
July 12, 2012
7/18/2012 July 12, 2012
Prokarium Acquires Key Oral Vaccine Technology Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc....
June 25, 2012
6/27/2012 June 25, 2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...
June 25, 2012
AmDerma & Oculus Enter Multi-Country Agreement June 25, 2012
AmDerma Pharmaceuticals, LLC, a privately owned company (and parent company of Quinnova Pharmaceuticals, Inc.) and Oculus Innovative Sciences recently announced...Company Profiles
December 5, 2025
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...
